简体中文 | 繁體中文 | English

Press Releases

2018-12-04 10:01 Moody’s Analytics Wins in Regulation Asia Awards for Excellence 2018
2018-12-04 09:56 Argon Design Licenses Argon Streams AV1 to Realtek Semiconductor
2018-12-04 09:54 Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
2018-12-04 09:52 Kyriba Continues to Expand its #1 Global Solutions Ecosystem with New WorldFirst Partnership
2018-12-04 09:50 Vitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
2018-12-03 17:37 Char Popp Joins PSB as Senior Vice President and Global Head of Qualitative Research
2018-12-03 16:05 FPT Television Selects Telaria to Manage and Monetize Connected TV Inventory Programmatically
2018-12-03 15:07 An Unprecedented Initiative Supported By the United Arab Emirates
2018-12-03 15:02 Idemitsu Kosan: Construction of an OLED Materials Plant in China
2018-12-03 14:56 MIRAI DINING Co., Ltd.: KYOTO MISO RAMEN KAZU to Open on December 1st, 2018
2018-12-03 10:47 GVIDO MUSIC Representative Director and CEO to Also Serve as President
2018-12-03 10:35 2Easy: a Hong Kong Startup is Targeting to Launch a Few More Asian Nations
2018-12-03 10:31 Tokyo Gas Switches to Rimini Street Support for SAP Applications
2018-12-03 10:28 Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018
2018-12-03 10:26 Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
2018-12-03 10:24 Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
2018-12-03 10:22 Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
2018-12-03 10:19 Splunk Announces Integrations With New Amazon Web Services Security Hub
2018-12-03 09:30 Citco Launches CitcoConnect: a New Stand-Alone Solution for Secure Data Sharing & Digital Investment
2018-11-30 18:11 Cisive Announces Acquisition of Pre-Employment Screening (PES) Business from Blue Umbrella

Business Wire Weibo

Industries

Latest Releases